Page last updated: 2024-10-30

loratadine and Basophilic Leukemia, Acute

loratadine has been researched along with Basophilic Leukemia, Acute in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berthon, B1
Taudou, G1
Combettes, L1
Czarléwski, W1
Carmi-Leroy, A1
Marchand, F1
Weyer, A1

Other Studies

1 other study available for loratadine and Basophilic Leukemia, Acute

ArticleYear
In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3).
    Biochemical pharmacology, 1994, Mar-02, Volume: 47, Issue:5

    Topics: Animals; Antibodies, Anti-Idiotypic; Basophils; Calcium; Cytosol; Dinitrobenzenes; Dinitrophenols; H

1994